Abstract
Proteinuria is utilized to screen for underlying kidney disease and serves as a marker of disease progression. The aim of this study was to test the hypothesis that patients with proteinuria will have a higher frequency of urine dipstick positive for leukocytes as an index of noninfectious renal inflammation. In this retrospective analysis, 1,099 urine specimens were evaluated from 676 patients. Proteinuria was present in 39% of the samples and leukocyturia in 5.1%. The percentage of urines that were dipstick positive for leukocytes was similar in those specimens with or without proteinuria. However, in patients with proteinuria and concomitant leukocyturia, the mean serum creatinine concentration was higher (P=0.003) and the calculated GFR was lower (P=0.01) compared to those without this additional abnormality. These differences were noted despite similar age, gender distribution, and array of underlying diseases in these two groups. Based on these findings, urine dipstick testing for leukocytes as a primary means of screening otherwise healthy children for serious renal disease is of little value. However, in patients with established proteinuria, a positive dipstick result for leukocytes is a simple means of identifying those with more prominent noninfectious renal inflammation, a process which may promote kidney disease progression. This finding may serve as an early marker of the severity of renal injury, regardless of whether the primary process is glomerular or tubular.
References
Jafar TH, Stark PC, Landa M, Maschio G, Marcantoni C, de Jong PE (2001) Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 60:1131–1140
Eknoyan G, Hostetter T, Bakaris GL, Hebert L, Levey AS, Parving HH (2003) Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 42:617–622
Ruggenenti P, Perna A, Remuzzi G, GISEN Investigators (2003) Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int 63:2254–2261
Campbell R, Sangalli F, Pertricucci E, Aros C, Viscarra C, Perna A (2003) Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int 63:1094–1103
Zoja C, Benigni A, Remuzzi G (2004) Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hyperten 13:31–37
Abbate M, Zoja C, Rottoli D, Corna D, Tomasoni S, Remuzzi G (2002) Proximal tubular cells promote fibrogenesis by TGF- beta1-mediated induction of peritubular myofibroblasts. Kidney Int 61:2066–2077
Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C (2002) Protein overload-induced- NF-kappaB activation in proximal tubular cells required H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol 13:1179–1189
Fujihara CK, Malheiros DM, Zatz R, Noronha ID (1998) Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 54:1510–1519
Remuzzi G, Zoja C, Gagliardini E, Corna D, Abbate M, Benigni A (1999) Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol 10:1542–1549
Kramer S, Loof T, Martini S, Ruckert M, Wang Y, Bohler T, Shimuzu F, Kawachi H, Neumeyer HH, Peters H (2005) Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril. Am J Physiol 289:F359–F36811
Schwartz GJ, Brion LP, Spitzer A (1987). The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am 34:571–590
Penders J, Fiers T, Delanghe JR (2002) Quantitative evaluation of urinalysis test strips. Clin Chem 48:2236–2241
Eddy AA (2004) Proteinuria and interstitial injury. Nephrol Dial Transplant 19:277–281
Perico N, Codreanu I, Schieppati A, Remuzzi G (2005) The future of renoprotection. Kidney Int 97(Suppl):S95–S101
Festa A, D’Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703–1710
Lane JT (2004) Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective. Am J Physiol 286:F442–F450
Ibsen H, Olsen MH, Wachtell, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y (2005) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction on hypertension study. Hypertension 45:198–202
Rodriguez-Iturbe B, Quiroz Y, Shakarami A, Li Z, Vaziri ND (2005) Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat. Kidney Int 68:1041–1047
Park YH, Choi JY, Chung HS, Koo JW, Kim SY, Namgoong MK, Park YS, Yoo KH, Lee KY, Lee DY, Lee SJ, Lee JE, Chung WY, Hah TS, Cheong HI, Choi Y, Lee KS (2005) Hematuria and proteinuria in a mass school urine screening test. Pediatr Nephrol 20:1126–1130
Jafar TH, Chaturvedi N, Hatcher J, Khan I, Rabbani A, Khan AQ, Portman R, Schmid CH, Levey AS (2005) Proteinuria in South Asian children: prevalence and determinants. Pediatr Nephrol 20:1458–1465
Roberti I, Reisman L (2001) Serial evaluation of cell surface markers for immune activation after acute renal allograft rejection by urine flow cytometry -correlation with clinical outcome. Transplantation 71:1317–1320
Acknowledgements
We thank Penina Tarshish, MD, and Bernard Gauthier, MD, for their careful review of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koss, S., Perl, A., Wieder, A. et al. Proteinuria and renal disease: prognostic value of urine dipstick testing for leukocytes. Pediatr Nephrol 21, 584–587 (2006). https://doi.org/10.1007/s00467-006-0015-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0015-8